中成药临床应用实践指南的报告规范(RIGHT for CPM)解读
Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines(RIGHT for CPM)
王憭瑶 1潘赫婧 1张乐 2王文雅 2廖星2
作者信息
- 1. 浙江中医药大学基础医学院,杭州 310053
- 2. 中国中医科学院中医临床基础医学研究所循证医学基础研究室,北京 100700
- 折叠
摘要
中成药临床应用实践指南在国家药物目录遴选、医疗机构处方集制定、中成药临床合理用药等方面提供重要的参考依据,是中医药指南的重要组成部分.中成药作为中国药品供应保障体系的重要组成部分,在许多疾病门类中均发挥着重要的治疗、预防及保健作用,但也存在乱用甚至滥用现象.为了规范中成药的合理应用,浙江中医药大学研究团队基于国际实践指南报告标准(RIGHT)清单框架,研制了中成药临床应用实践指南的报告规范(RIGHT for CPM).RIGHT for CPM清单汇集了已发布的中成药指南、现有的中医药报告清单、RIGHT清单及其扩展版中的关键信息,形成初始报告清单条目池,邀请不同学科的17位专家进行2轮德尔菲问卷调研后形成,最后由来自国内外中医药研究、报告指南领域的18位权威专家审查并批准发布.RIGHT for CPM清单较RIGHT清单新增16个亚条目和修订了 RIGHT清单的2个亚条目,更加突出中成药指南的报告特点,考虑到了中成药遴选及入选标准、政策准入、适应证候和症状、联合用药说明、特殊人群用药、使用注意事项、西医医师用药建议等方面,可进一步提升中成药指南报告质量和透明度,促进中成药指南的规范化报告和中成药的临床合理应用.该文就RIGHT for CPM清单的研制过程、重点突出中成药指南特色的条目内容进行解读,以期促进RIGHT for CPM清单的推广应用.
Abstract
The clinical practice guidelines for Chinese patent medicines(CPM)provide reference for the selection of national drug catalogs,the formulation of prescription collections in medical institutions,and the clinical use of CPM,constituting an important part of traditional Chinese medicine(TCM)guidelines.As a crucial part of Chinese drug supply guarantee system,CPM plays an important role in the treatment,prevention,and healthcare of many disease categories,whereas the application of CPM has problems of misuse and even abuse.To standardize the application of CPM,a research team at Zhejiang Chinese Medical University developed the Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines(RIGHT for CPM)based on the RIGHT checklist framework.The RIGHT for CPM checklist gathers key information from published CPM guidelines,existing TCM reporting checklists,and the RIGHT checklist and its extensions to form an initial pool of reporting items.Seventeen experts from different disciplines were invited to conduct two rounds of Delphi surveys,and the final checklist was reviewed and approved for publication by 18 leading experts in TCM research and guideline reporting from China and abroad.The RIGHT for CPM checklist adds 16 sub-items and revises 2 sub-items on the basis of the RIGHT checklist,highlighting the characteristics of CPM guideline reporting.It considers CPM selection and inclusion criteria,policy access,indications and symptoms,drug combination instructions,drug use in special populations,precautions,and recommendations of Western medical physicians,among others.This can further improve the quality and transparency of CPM guideline reporting,promote standardized reporting of CPM guidelines,and facilitate the rational clinical use of CPM.This article interprets the development process of the RIGHT for CPM checklist and the items that highlight the characteristics of CPM guidelines,with a view to promoting the application of the RIGHT for CPM checklist.
关键词
中成药/临床实践指南/报告规范/中成药临床应用实践指南的报告规范(RIGHT/for/CPM)/解读Key words
Chinese patent medicine/clinical practice guidelines/reporting checklist/Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines(RIGHT for CPM)/interpretation引用本文复制引用
出版年
2025
国家科技期刊平台
NSTL
维普
万方数据